BeOne Medicines Ltd. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.51B | 1.50B | 1.41B | 1.32B | 1.12B | 1.13B | 1.00B | 929.2M |
| Cost of Goods Sold | 167.2M | 142.4M | 196.5M | 164.6M | 165.0M | 160.6M | 170.5M | 138.1M |
| Gross Profit | 1.35B | 1.36B | 1.22B | 1.15B | 952.3M | 967.3M | 831.1M | 791.0M |
| R&D Expenses | 541.2M | 615.4M | 523.7M | 524.9M | 481.9M | 542.0M | 496.2M | 454.5M |
| Operating Expenses | 1.10B | 1.17B | 1.05B | 1.06B | 941.2M | 1.05B | 951.4M | 898.2M |
| Operating Income | 249.9M | 185.0M | 163.1M | 87.9M | 11.1M | -79.4M | -120.3M | -107.2M |
| Other Income / Gains | 9.3M | -35.8M | -15.9M | 11.7M | 9.8M | -5.9M | 22.0M | 1.2M |
| Net Income | 227.4M | 66.5M | 124.8M | 94.3M | 1.3M | -151.9M | -121.3M | -120.4M |
| EPS (Diluted) | 26.65 | 7.67 | 14.69 | 0.87 | 0.01 | -1.43 | -1.16 | -1.15 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.89 | 0.905 | 0.861 | 0.875 | 0.852 | 0.858 | 0.83 | 0.851 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 555.1M | 555.3M | 529.0M | 537.9M | 459.3M | 504.7M | 455.2M | 443.7M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 1.26B | 1.31B | 1.25B | 1.23B | 1.11B | 1.21B | 1.12B | 1.04B |
| Interest Income | 27.7M | 58.1M | 3.0M | 3.5M | 12.8M | 7.8M | 10.6M | 13.2M |
| Interest Expense | 32.9M | 0 | 0 | 0 | 7.0M | 0 | 0 | 0 |
| Depreciation And Amortization | 41.1M | 36.0M | 37.3M | 35.6M | 32.8M | 50.2M | 71.3M | 24.1M |
| Ebitda | 333.2M | 249.0M | 200.4M | 123.5M | 60.7M | -29.2M | -49.0M | -83.1M |
| Ebitdaratio | 0.22 | 0.166 | 0.142 | 0.094 | 0.054 | -0.026 | -0.049 | -0.089 |
| Operating Income Ratio | 0.165 | 0.124 | 0.115 | 0.067 | 0.01 | -0.07 | -0.12 | -0.115 |
| Income Before Tax | 259.2M | 149.2M | 147.2M | 99.5M | 20.9M | -85.4M | -98.3M | -105.9M |
| Income Before Tax Ratio | 0.171 | 0.10 | 0.104 | 0.076 | 0.019 | -0.076 | -0.098 | -0.114 |
| Income Tax Expense | 31.9M | 82.7M | 22.3M | 5.2M | 19.6M | 66.5M | 23.0M | 14.5M |
| Net Income Ratio | 0.15 | 0.044 | 0.088 | 0.072 | 0.001 | -0.135 | -0.121 | -0.13 |
| Epsdiluted | 25.48 | 6.76 | 13.52 | 0.84 | 0.01 | -1.43 | -1.16 | -1.15 |
| Weighted Average Shs Out | 111.0M | 109.1M | 110.2M | 108.6M | 106.9M | 106.3M | 104.7M | 104.7M |
| Weighted Average Shs Out Dil | 115.8M | 113.4M | 114.5M | 112.8M | 111.2M | 106.3M | 104.7M | 104.7M |